Skip to content
Screener

Bausch + Lomb BLCO Q2 2025 earnings

Reported July 30, 2025 · Before market open

Revenue$1.3BBeat by $3.9M
EPS$0.07Beat by $0.01
Revenue estimate$1.3B
EPS estimate$0.06

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.4B
EPS estimate$0.21

Financials

Q2 2025

Income statement

See full
Revenue$1.3B+5.1%
Operating income-$11.0M-142%
Net income-$62.0M+58.9%
EPS (diluted)-$0.18+58.1%

Balance sheet

See full
Cash & equivalents$272.0M-9.9%
Total debt$5.0B+7.1%
Total equity$6.4B-1.0%
Total assets$13.8B+4.4%

Cash flow

See full
Operating cash flow$35.0M+133%
CapEx$89.0M+23.6%
Free cash flow-$54.0M+5.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$4.25B-16.6%
Enterprise value$8.94B-5.2%
P/S0.9×-0.3×

Profitability

See full
Operating margin0.7%-2.0pp
Net margin-5.6%-1.7pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-4.2%-1.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.1×

Segments

By segment

See full
Vision Care$753.0M+8.0%
Pharmaceuticals$260.0M+6.1%
Surgical$216.0M+3.3%

By product

See full
OTC$482.0M+7.8%
Devices$472.0M+6.1%
Branded and Other Generics$58.0M-23.7%

FAQ

When did Bausch + Lomb report Q2 2025 earnings?
Bausch + Lomb (BLCO) reported Q2 2025 earnings on July 30, 2025 before market open.
What were Bausch + Lomb's Q2 2025 revenue and EPS?
Bausch + Lomb reported revenue of $1.3B and eps of $0.07 for Q2 2025.
Did Bausch + Lomb beat estimates in Q2 2025?
Revenue beat the consensus estimate of $1.3B by $3.9M. EPS beat the consensus estimate of $0.06 by $0.01.
How did Bausch + Lomb's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.1% from $1.2B a year earlier and eps declined 46.2% from $0.13.
Where can I find Bausch + Lomb's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001860742-25-000016) and the 10-Q periodic report (0001860742-25-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.